We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Phase 3 SYNCHRONIZE-1 analysis: weight loss 13-16.6%, but 19% discontinuations due to side effects. Is it worth the risk? Read the full review.